Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals

BACKGROUND: The development of new drugs for the treatment of diabetes mellitus (DM) is critically important. Insulin resistance (IR) is one of the main problems associated with type-2 DM (T2DM) seen in clinics. GW0742, a selective peroxisome proliferator-activated receptor (PPAR)-δ agonist, has bee...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Drug Des Devel Ther
Huvudupphovsmän: Niu, Ho-Shan, Ku, Po-Ming, Niu, Chiang-Shan, Cheng, Juei-Tang, Lee, Kung-Shing
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610778/
https://ncbi.nlm.nih.gov/pubmed/26508837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S95045
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk